BioCatalystWatch
AARDWorkspace / AARD / OverviewCompany library
Aardvark Therapeutics, Inc. logo

Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc. (AARD)

Website

Price
Market cap
Next catalystExpected Q1 2027ARD-101 · Regulatory meetingSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

History / paused

ARD-101

TAS2Rs

PreINDP1P2P3FilingApproved
ARD-101

TAS2Rs

PreINDP1P2P3FilingApproved
ARD-101

TAS2Rs

PreINDP1P2P3FilingApproved

TAS2Rs × DPP-4

PreINDP1P2P3FilingApproved

TAS2Rs × DPP-4

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AARD PR & News

PR & News

AARD SEC archive